AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Pfizer Ltd. Board/Management Information 2023

Aug 18, 2023

60507_rns_2023-08-18_f3308995-60f1-4ebd-a4b3-8341e086c2e9.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

August 18, 2023

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sir/Madam,

Sub: Intimation regarding change in Senior Management Personnel of the Company.

Ref.: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company hereby wishes to inform that –

Mr. Manish Mishra – Category Lead, Vaccines will be transitioning to a different role within Pfizer Group effective September 1, 2023, and shall accordingly cease to be a Senior Management Personnel effective the said date.
Ms. Sudeshna Mitra – Healthcare Solutions Partner Lead will be moving to a different role within the Company effective September 1, 2023, and shall accordingly cease to be a Senior Management Personnel from the said date.